Breaking News Instant updates and real-time market news.

TDOC

Teladoc

$182.44 /

+1.065 (+0.59%)

09:10
04/26/21
04/26
09:10
04/26/21
09:10

Teladoc names Claus Jensen as chief innovation officer

Teladoc Health has named Claus Jensen as chief innovation officer to lead the research and development team. "We are excited to welcome Claus to the Teladoc Health team to lead our innovation efforts," said Jason Gorevic, Teladoc Health CEO. "With deep experience transforming hospital systems and health plans, Claus is the right leader at the right time to accelerate Teladoc Health's vision of connecting the healthcare experience from hospital to home." Jensen joins Teladoc Health from Memorial Sloan Kettering Cancer Center (MSK), where he served as chief digital officer and head of technology.

  • 28

    Apr

  • 10

    May

  • 17

    May

TDOC Teladoc
$182.44 /

+1.065 (+0.59%)

04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
04/15/21 Needham
Needham starts Teladoc at Buy citing 'durable growth opportunity'
04/15/21 Needham
Teladoc initiated with a Buy at Needham
04/08/21 Piper Sandler
Teladoc recent weakness a buying opportunity, says Piper Sandler

TODAY'S FREE FLY STORIES

Initiation
Agios Pharmaceuticals initiated with a Buy at BofA » 06:20
12/03/21
12/03
06:20
12/03/21
06:20
AGIO

Agios Pharmaceuticals

$34.78 /

-0.23 (-0.66%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

06:19 Today BofA
Agios Pharmaceuticals initiated with a Buy at BofA
06:04 Today BofA
Agios Pharmaceuticals initiated with a Buy at BofA
07/30/21
Fly Intel: Top five analyst downgrades
07/30/21 H.C. Wainwright
Agios Pharmaceuticals price target raised to $93 from $88 at H.C. Wainwright
AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

Initiation
Genesis Energy reinstated with a Buy at Citi » 06:19
12/03/21
12/03
06:19
12/03/21
06:19
GEL

Genesis Energy

$10.73 /

+0.625 (+6.19%)

Citi analyst Timm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GEL Genesis Energy
$10.73 /

+0.625 (+6.19%)

GEL Genesis Energy
$10.73 /

+0.625 (+6.19%)

11/23/21 Capital One
Genesis Energy downgraded to Equalweight from Overweight at Capital One
10/14/21 Barclays
Genesis Energy downgraded to Equal Weight from Overweight at Barclays
05/13/21 Wells Fargo
Genesis Energy upgraded to Equal Weight from Underweight at Wells Fargo
GEL Genesis Energy
$10.73 /

+0.625 (+6.19%)

GEL Genesis Energy
$10.73 /

+0.625 (+6.19%)

Periodicals
Netflix loses challenge in suit on poaching Fox execs, Bloomberg says » 06:18
12/03/21
12/03
06:18
12/03/21
06:18
NFLX

Netflix

$615.82 /

-1.93 (-0.31%)

, FOXA

Fox Corp.

$35.35 /

+0.95 (+2.76%)

, FOX

Fox Corp.

$32.85 /

+0.61 (+1.89%)

Netflix (NFLX) lost its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

11/04/21 Deutsche Bank
Fox Corp. price target raised to $47 from $43 at Deutsche Bank
09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Rosenblatt
Rosenblatt upgrades Fox on expected favorable FanDuel outcome
09/30/21 Rosenblatt
Fox Corp. upgraded to Buy from Neutral at Rosenblatt
FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

08/05/21 Guggenheim
Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
05/06/21 RBC Capital
Fox Corp. price target raised to $42 from $36 at RBC Capital
05/06/21 UBS
Fox Corp price target raised to $39 from $30 at UBS
04/27/21 Morgan Stanley
Fox Corp. price target raised to $45 from $36 at Morgan Stanley
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

  • 16
    Nov
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

Periodicals
Citi applies for securities license in China, WSJ reports » 06:17
12/03/21
12/03
06:17
12/03/21
06:17
C

Citi

$63.80 /

+1.29 (+2.06%)

Citigroup has applied for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
C Citi
$63.80 /

+1.29 (+2.06%)

C Citi
$63.80 /

+1.29 (+2.06%)

10/15/21 BMO Capital
Citi price target raised to $86 from $84 at BMO Capital
10/11/21 Jefferies
Citi price target raised to $87 from $81 at Jefferies
09/29/21 Oppenheimer
Morgan Stanley downgraded to Perform at Oppenheimer on valuation
07/15/21 Piper Sandler
Citi price target lowered to $91 from $95 at Piper Sandler
C Citi
$63.80 /

+1.29 (+2.06%)

C Citi
$63.80 /

+1.29 (+2.06%)

C Citi
$63.80 /

+1.29 (+2.06%)

C Citi
$63.80 /

+1.29 (+2.06%)

Recommendations
DocuSign price target lowered to $231 from $389 at Citi » 06:17
12/03/21
12/03
06:17
12/03/21
06:17
DOCU

DocuSign

$233.83 /

+2.77 (+1.20%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

04:47 Today Piper Sandler
DocuSign downgraded to Neutral from Overweight at Piper Sandler
04:45 Today UBS
DocuSign downgraded to Neutral from Buy at UBS
04:43 Today JPMorgan
DocuSign downgraded to Underweight from Neutral at JPMorgan
10/06/21
DocuSign participates in a conference call with Benchmark
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

Syndicate
Esperion 32.143M share Spot Secondary priced at $7.00 » 06:16
12/03/21
12/03
06:16
12/03/21
06:16
ESPR

Esperion

$8.99 /

+0.925 (+11.47%)

H.C. Wainwright acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESPR Esperion
$8.99 /

+0.925 (+11.47%)

ESPR Esperion
$8.99 /

+0.925 (+11.47%)

10/19/21 Cowen
Esperion price target lowered to $30 from $60 at Cowen
10/18/21 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
10/14/21 Morgan Stanley
Morgan Stanley cuts Esperion to Underweight, lacks confidence in near-term
10/14/21 Morgan Stanley
Esperion downgraded to Underweight from Equal Weight at Morgan Stanley
ESPR Esperion
$8.99 /

+0.925 (+11.47%)

ESPR Esperion
$8.99 /

+0.925 (+11.47%)

Initiation
Radius Health initiated with an Underperform at BofA » 06:15
12/03/21
12/03
06:15
12/03/21
06:15
RDUS

Radius Health

$16.05 /

+0.505 (+3.25%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

06:04 Today BofA
Radius Health initiated with an Underperform at BofA
11/09/21 H.C. Wainwright
Radius Health price target lowered to $23 from $26 at H.C. Wainwright
10/21/21 H.C. Wainwright
Radius Health price target raised to $26 from $19 at H.C. Wainwright
10/20/21 Stifel
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

Recommendations
Kroger price target raised to $38 from $37 at Barclays » 06:14
12/03/21
12/03
06:14
12/03/21
06:14
KR

Kroger

$44.61 /

+4.4 (+10.94%)

Barclays analyst Karen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
09/16/21 MKM Partners
Albertsons price target raised to $27 from $17 at MKM Partners
09/13/21 BMO Capital
Kroger price target raised to $39 from $36 at BMO Capital
09/13/21 MKM Partners
Kroger price target raised to $44 from $40 at MKM Partners
KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

Recommendations
GMS Inc. price target raised to $61 from $56 at Barclays » 06:14
12/03/21
12/03
06:14
12/03/21
06:14
GMS

GMS Inc.

$57.74 /

+1.36 (+2.41%)

Barclays analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

09/08/21 Barclays
GMS Inc. price target raised to $56 from $49 at Barclays
09/03/21 Truist
GMS Inc. price target raised to $62 from $52 at Truist
09/03/21 Baird
GMS Inc. price target raised to $62 from $58 at Baird
06/29/21 Barclays
GMS Inc. price target raised to $49 from $37 at Barclays
GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

Recommendations
Cabot price target raised to $72 from $70 at Barclays » 06:13
12/03/21
12/03
06:13
12/03/21
06:13
CBT

Cabot

$53.53 /

+2.11 (+4.10%)

Barclays analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBT Cabot
$53.53 /

+2.11 (+4.10%)

CBT Cabot
$53.53 /

+2.11 (+4.10%)

11/29/21 Loop Capital
Cabot price target raised to $86 from $81 at Loop Capital
11/16/21 Deutsche Bank
Cabot price target raised to $62 from $58 at Deutsche Bank
07/23/21 JPMorgan
Cabot upgraded to Overweight from Neutral at JPMorgan
07/01/21 Loop Capital
Cabot upgraded to Buy at Loop Capital on 'solid fundamental outlook'
CBT Cabot
$53.53 /

+2.11 (+4.10%)

Hot Stocks
Patterson-UTI reports an average of 106 drilling rigs operating in November » 06:13
12/03/21
12/03
06:13
12/03/21
06:13
PTEN

Patterson-UTI

$7.29 /

+0.36 (+5.19%)

Patterson-UTI reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTEN Patterson-UTI
$7.29 /

+0.36 (+5.19%)

PTEN Patterson-UTI
$7.29 /

+0.36 (+5.19%)

11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 BofA
Patterson-UTI upgraded to Buy from Underperform at BofA
10/25/21 Barclays
Patterson-UTI price target raised to $11 from $9 at Barclays
09/08/21 RBC Capital
Patterson-UTI assumed with a Sector Perform at RBC Capital
PTEN Patterson-UTI
$7.29 /

+0.36 (+5.19%)

PTEN Patterson-UTI
$7.29 /

+0.36 (+5.19%)

Downgrade
Eagle Materials downgraded to Hold from Buy at Loop Capital » 06:12
12/03/21
12/03
06:12
12/03/21
06:12
EXP

Eagle Materials

$158.31 /

+5.305 (+3.47%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXP Eagle Materials
$158.31 /

+5.305 (+3.47%)

EXP Eagle Materials
$158.31 /

+5.305 (+3.47%)

10/26/21 Citi
Eagle Materials price target raised to $170 from $167 at Citi
10/19/21 Exane BNP Paribas
Eagle Materials downgraded to Neutral from Outperform at Exane BNP Paribas
09/21/21 Loop Capital
Eagle Materials stock price pullback excessive, says Loop Capital
08/30/21 Berenberg
Eagle Materials upgraded to Buy from Hold at Berenberg
EXP Eagle Materials
$158.31 /

+5.305 (+3.47%)

EXP Eagle Materials
$158.31 /

+5.305 (+3.47%)

Hot Stocks
Bank of Montreal to repurchase up to 22.5M shares » 06:11
12/03/21
12/03
06:11
12/03/21
06:11
BMO

Bank of Montreal

$105.21 /

+1.67 (+1.61%)

"Looking ahead to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

11/23/21 Scotiabank
Bank of Montreal price target raised to C$161 from C$147 at Scotiabank
11/10/21 Desjardins
Bank of Montreal upgraded to Buy from Hold at Desjardins
09/07/21 Barclays
Bank of Montreal upgraded to Equal Weight from Underweight at Barclays
08/26/21 Desjardins
Bank of Montreal price target raised to C$138 from C$133 at Desjardins
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

Initiation
Stoke Therapeutics initiated with a Buy at BofA » 06:11
12/03/21
12/03
06:11
12/03/21
06:11
STOK

Stoke Therapeutics

$23.83 /

+0.83 (+3.61%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

06:04 Today BofA
Stoke Therapeutics initiated with a Buy at BofA
11/22/21 JPMorgan
Stoke Therapeutics upgraded to Overweight from Neutral at JPMorgan
08/17/21 Cantor Fitzgerald
Stoke Therapeutics price target lowered to $68 from $76 at Cantor Fitzgerald
06/30/21 Canaccord
Stoke Therapeutics leader in Dravet Syndrome approach, says Canaccord
STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

Initiation
Old Dominion initiated with a Hold at Benchmark » 06:11
12/03/21
12/03
06:11
12/03/21
06:11
ODFL

Old Dominion

$356.68 /

+5.82 (+1.66%)

Benchmark analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ODFL Old Dominion
$356.68 /

+5.82 (+1.66%)

ODFL Old Dominion
$356.68 /

+5.82 (+1.66%)

11/30/21 KeyBanc
Old Dominion price target raised to $375 from $350 at KeyBanc
11/16/21 UBS
Old Dominion downgraded to Neutral from Buy at UBS
11/09/21 Morgan Stanley
Morgan Stanley cuts Old Dominion to Equal Weight, thinks bar may be too high
11/09/21 Morgan Stanley
Old Dominion downgraded to Equal Weight from Overweight at Morgan Stanley
ODFL Old Dominion
$356.68 /

+5.82 (+1.66%)

Hot Stocks
Bank of Montreal increases quarterly dividend to C$1.33 per share » 06:11
12/03/21
12/03
06:11
12/03/21
06:11
BMO

Bank of Montreal

$105.21 /

+1.67 (+1.61%)

Concurrent with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

11/23/21 Scotiabank
Bank of Montreal price target raised to C$161 from C$147 at Scotiabank
11/10/21 Desjardins
Bank of Montreal upgraded to Buy from Hold at Desjardins
09/07/21 Barclays
Bank of Montreal upgraded to Equal Weight from Underweight at Barclays
08/26/21 Desjardins
Bank of Montreal price target raised to C$138 from C$133 at Desjardins
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

Recommendations
Marvell price target raised to $100 from $76 at Deutsche Bank » 06:10
12/03/21
12/03
06:10
12/03/21
06:10
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

06:04 Today Piper Sandler
Marvell price target raised to $100 from $70 at Piper Sandler
05:57 Today Cowen
Marvell upgraded to Outperform after 'watershed' quarter at Cowen
05:40 Today Cowen
Marvell upgraded to Outperform from Market Perform at Cowen
05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Earnings
Bank of Montreal reports Q4 adjusted EPS C$3.33 vs. C$3.44 last year » 06:09
12/03/21
12/03
06:09
12/03/21
06:09
BMO

Bank of Montreal

$105.21 /

+1.67 (+1.61%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

11/23/21 Scotiabank
Bank of Montreal price target raised to C$161 from C$147 at Scotiabank
11/10/21 Desjardins
Bank of Montreal upgraded to Buy from Hold at Desjardins
09/07/21 Barclays
Bank of Montreal upgraded to Equal Weight from Underweight at Barclays
08/26/21 Desjardins
Bank of Montreal price target raised to C$138 from C$133 at Desjardins
BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

BMO Bank of Montreal
$105.21 /

+1.67 (+1.61%)

Initiation
Cidara Therapeutics assumed with a Buy at H.C. Wainwright » 06:09
12/03/21
12/03
06:09
12/03/21
06:09
CDTX

Cidara Therapeutics

$1.46 /

-0.025 (-1.69%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

09/22/21 WBB Securities
Cidara Therapeutics upgraded to Strong Buy from Buy at WBB Securities
03/04/21 Aegis
Cidara Therapeutics initiated with a Buy at Aegis
CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

  • 08
    Oct
CDTX Cidara Therapeutics
$1.46 /

-0.025 (-1.69%)

Recommendations
Beyond Meat price target lowered to $61 from $72 at Piper Sandler » 06:08
12/03/21
12/03
06:08
12/03/21
06:08
BYND

Beyond Meat

$67.39 /

+1.15 (+1.74%)

, OTLY

Oatly Group

$8.22 /

-0.17 (-2.03%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

11/30/21
Fly Intel: Top five analyst initiations
11/30/21 HSBC
HSBC starts Beyond Meat with sell on 'increasingly competitive' market
11/29/21 HSBC
Beyond Meat initiated with a Reduce at HSBC
11/15/21 Cowen
Beyond Meat price target lowered to $79 from $101 at Cowen
OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

11/30/21 HSBC
HSBC starts Oatly at sell, says management overestimated market
11/30/21 HSBC
Oatly Group initiated with a Reduce at HSBC
11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 Atlantic Equities
Oatly downgraded to Neutral on limited visibility at Atlantic Equities
BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

  • 20
    May
BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

BYND Beyond Meat
$67.39 /

+1.15 (+1.74%)

OTLY Oatly Group
$8.22 /

-0.17 (-2.03%)

Upgrade
Maxeon Solar upgraded to Buy from Neutral at BofA » 06:06
12/03/21
12/03
06:06
12/03/21
06:06
MAXN

Maxeon Solar

$17.09 /

+0.145 (+0.86%)

BofA analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

11/16/21 Roth Capital
Roth says court restoring solar 'bifi' exemption a 'major surprise'
11/11/21 Morgan Stanley
Commerce rejection negative for First Solar, Maxeon, says Morgan Stanley
10/05/21 Raymond James
Maxeon Solar downgraded to Outperform from Strong Buy at Raymond James
08/09/21 Morgan Stanley
Maxeon Solar initiated with an Equal Weight at Morgan Stanley
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

  • 16
    Apr
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

Earnings
Big Lots cuts FY21 EPS view to $5.70-$5.85 from $5.90-$6.05, consensus $5.97 » 06:06
12/03/21
12/03
06:06
12/03/21
06:06
BIG

Big Lots

$43.62 /

+0.935 (+2.19%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

Recommendations
Ulta Beauty price target raised to $475 from $433 at Piper Sandler » 06:05
12/03/21
12/03
06:05
12/03/21
06:05
ULTA

Ulta Beauty

$383.13 /

+12.8 (+3.46%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

10/20/21 Cowen
Ulta Beauty price target lowered to $440 from $490 at Cowen
10/20/21 BofA
Ulta Beauty price target lowered to $400 from $430 at BofA
10/20/21 William Blair
Ulta Beauty should be bought on yesterday's selloff, says William Blair
10/20/21 Baird
Ulta Beauty risk/reward attractive at current levels, says Baird
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

Earnings
Big Lots sees Q4 EPS $2.05-$2.20, consensus $2.39 » 06:05
12/03/21
12/03
06:05
12/03/21
06:05
BIG

Big Lots

$43.62 /

+0.935 (+2.19%)

Sees Q4 comparable sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

Initiation
Radius Health initiated with an Underperform at BofA » 06:04
12/03/21
12/03
06:04
12/03/21
06:04
RDUS

Radius Health

$16.05 /

+0.505 (+3.25%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

11/09/21 H.C. Wainwright
Radius Health price target lowered to $23 from $26 at H.C. Wainwright
10/21/21 H.C. Wainwright
Radius Health price target raised to $26 from $19 at H.C. Wainwright
10/20/21 Stifel
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel
10/20/21 Stifel
Stifel ups Radius Health target to $22 following EMERALD Phase 3 trial data
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.